Alzheimer's disease transcriptional landscape in ex-vivo human microglia

Microglia are resident immune cells of the brain and are implicated in the etiology of Alzheimer's Disease (AD) and other diseases. Yet the cellular and molecular processes regulating their function throughout the course of the disease are poorly understood. Here, we present the transcriptional...

Full description

Saved in:
Bibliographic Details
Published inResearch square
Main Authors Roussos, Panos, Kosoy, Roman, Fullard, John, Bendl, Jaroslav, Kleopoulos, Steven, Shao, Zhiping, Argyriou, Stathis, Mathur, Deepika, Vicari, James, Ma, Yixuan, Humphrey, Jack, Brophy, Erica, Raj, Towfique, Katsel, Pavel, Voloudakis, Georgios, Lee, Donghoon, Bennett, David, Haroutunian, Vahram, Hoffman, Gabriel
Format Journal Article
LanguageEnglish
Published United States 26.01.2024
Online AccessGet more information

Cover

More Information
Summary:Microglia are resident immune cells of the brain and are implicated in the etiology of Alzheimer's Disease (AD) and other diseases. Yet the cellular and molecular processes regulating their function throughout the course of the disease are poorly understood. Here, we present the transcriptional landscape of primary microglia from 189 human postmortem brains, including 58 healthy aging individuals and 131 with a range of disease phenotypes, including 63 patients representing the full spectrum of clinical and pathological severity of AD. We identified transcriptional changes associated with multiple AD phenotypes, capturing the severity of dementia and neuropathological lesions. Transcript-level analyses identified additional genes with heterogeneous isoform usage and AD phenotypes. We identified changes in gene-gene coordination in AD, dysregulation of co-expression modules, and disease subtypes with distinct gene expression. Taken together, these data further our understanding of the key role of microglia in AD biology and nominate candidates for therapeutic intervention.